Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
83.7M
-
Shares change
-
+10.5M
-
Total reported value, excl. options
-
$823M
-
Value change
-
+$105M
-
Put/Call ratio
-
0.44
-
Number of buys
-
76
-
Number of sells
-
-64
-
Price
-
$9.83
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2021
189 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q1 2021.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83.7M shares
of 117M outstanding shares and own 71.38% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (12.6M shares), Bain Capital Life Sciences Investors, LLC (10.9M shares), BlackRock Inc. (8.56M shares), STATE STREET CORP (7.08M shares), Chicago Capital, LLC (5.79M shares), VANGUARD GROUP INC (5.32M shares), Avidity Partners Management LP (3.5M shares), GOLDMAN SACHS GROUP INC (3.27M shares), PFM Health Sciences, LP (2.99M shares), and BLAIR WILLIAM & CO/IL (2.26M shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.